Morningstar

Integra Lifesciences Holdings Corp IART

Morningstar Rating

Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm

Business Wire Sep 19, 2024 12:00pm
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference

GlobeNewswire Sep 4, 2024 8:01pm
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference

GlobeNewswire Sep 4, 2024 2:32pm
Integra LifeSciences Continues to Make Progress on Its ESG Strategy

GlobeNewswire Aug 21, 2024 8:15pm
Integra LifeSciences Reports Second Quarter 2024 Financial Results

GlobeNewswire Jul 29, 2024 10:00am
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART

Business Wire Jul 19, 2024 9:50pm
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts

GlobeNewswire Jul 15, 2024 12:00pm
Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024

GlobeNewswire Jul 15, 2024 12:00pm
Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings

Global News Select May 6, 2024 4:47pm
Integra LifeSciences to Buy Acclarent From Johnson & Johnson

Global News Select Dec 13, 2023 11:48am

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2024 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.